BC
VRTX icon

Brookfield Corp’s Vertex Pharmaceuticals VRTX Stock Holding History

Brookfield Corp’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-23,777
Closed -$8.37M – 522
2023
Q2 		$8.37M Buy
23,777
+22,614
+1,944% +$7.62M 0.03% 185
2023
Q1 		$366K Buy
+1,163
New +$349K ﹤0.01% 603
2022
Q3 		– Sell
-34,445
Closed -$9.71M – 782
2022
Q2 		$9.71M Buy
+34,445
New +$9.22M 0.04% 154
2022
Q1 		– Sell
-42,697
Closed -$9.38M – 799
2021
Q4 		$9.38M Buy
42,697
+29,816
+231% +$5.8M 0.04% 132
2021
Q3 		$2.34M Buy
12,881
+4,039
+46% +$789K 0.01% 321
2021
Q2 		$1.78M Buy
+8,842
New +$1.85M 0.01% 380

Other funds holding VRTX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return